高负担国家耐药结核病死亡率比较常规药敏试验与全基因组测序:一项多中心队列研究

Kathrin Zürcher, M. Reichmuth, M. Ballif, Chloé Loiseau, S. Borrell, Miriam, Reinhard, Veronika W Skrivankova, R. Hömke, P. Sander, A. Avihingsanon, A. Abimiku, Olivier Marcy, Jimena Collantes, E. Carter, R. Wilkinson, H. Cox, M. Yotebieng, R. Huebner, L. Fenner, E. Böttger, Sébastien, Gagneux, M. Egger
{"title":"高负担国家耐药结核病死亡率比较常规药敏试验与全基因组测序:一项多中心队列研究","authors":"Kathrin Zürcher, M. Reichmuth, M. Ballif, Chloé Loiseau, S. Borrell, Miriam, Reinhard, Veronika W Skrivankova, R. Hömke, P. Sander, A. Avihingsanon, A. Abimiku, Olivier Marcy, Jimena Collantes, E. Carter, R. Wilkinson, H. Cox, M. Yotebieng, R. Huebner, L. Fenner, E. Böttger, Sébastien, Gagneux, M. Egger","doi":"10.1016/S2666-5247(21)00044-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":344281,"journal":{"name":"The Lancet. Microbe","volume":"97 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":"{\"title\":\"Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study\",\"authors\":\"Kathrin Zürcher, M. Reichmuth, M. Ballif, Chloé Loiseau, S. Borrell, Miriam, Reinhard, Veronika W Skrivankova, R. Hömke, P. Sander, A. Avihingsanon, A. Abimiku, Olivier Marcy, Jimena Collantes, E. Carter, R. Wilkinson, H. Cox, M. Yotebieng, R. Huebner, L. Fenner, E. Böttger, Sébastien, Gagneux, M. Egger\",\"doi\":\"10.1016/S2666-5247(21)00044-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":344281,\"journal\":{\"name\":\"The Lancet. Microbe\",\"volume\":\"97 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet. Microbe\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/S2666-5247(21)00044-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet. Microbe","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/S2666-5247(21)00044-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Efficacy of different preoperative skin antiseptics on the incidence of surgical site infections: a systematic review, GRADE assessment, and network meta-analysis. Nirsevimab: a promising therapy for RSV. Correction to Lancet Microbe 2022; 3: e92. Health inequities and HTLV-1. Correction to Lancet Microbe 2021; published online Dec 13. https://doi.org/10.1016/S2666-5247(21)00241-X.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1